Sentinel Node Biopsy Confers No Added Protection to Patients with Melanoma

Overview

Journal J R Soc Med

Specialty General Medicine

Date 2007 Aug 8

PMID 17682035

Authors

Spyros Retsas

Affiliations

Soon will be listed here.

References

Retsas S, Henry K, Mohammed M, Macrae K . Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC): validation in a cohort of 1284 patients. Eur J Cancer. 2002; 38(4):511-6. DOI: 10.1016/s0959-8049(01)00394-x. View

Spitler L . Adjuvant therapy of melanoma. Oncology (Williston Park). 2002; 16(1 Suppl 1):40-8. View

Medalie N, Ackerman A . Sentinel lymph node biopsy has no benefit for patients with primary cutaneous melanoma metastatic to a lymph node: an assertion based on comprehensive, critical analysis: part II. Am J Dermatopathol. 2003; 25(6):473-84. DOI: 10.1097/00000372-200312000-00004. View

Thompson J, Scolyer R, Kefford R . Cutaneous melanoma. Lancet. 2005; 365(9460):687-701. DOI: 10.1016/S0140-6736(05)17951-3. View

Retsas S . Cutaneous melanoma. Lancet. 2005; 365(9476):2003-4. DOI: 10.1016/S0140-6736(05)66688-3. View

Pawlik T, Ross M, Thompson J, Eggermont A, Gershenwald J . The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes. J Clin Oncol. 2005; 23(21):4588-90. DOI: 10.1200/JCO.2005.12.245. View

Kang J, Wanek L, Essner R, Faries M, Foshag L, Morton D . Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma. J Clin Oncol. 2005; 23(21):4764-70. DOI: 10.1200/JCO.2005.20.537. View

Thomas J . Time to re-evaluate sentinel node biopsy in melanoma post-multicenter selective lymphadenectomy trial. J Clin Oncol. 2005; 23(36):9443-4. DOI: 10.1200/JCO.2005.04.0147. View

Verma S, Quirt I, McCready D, Bak K, Charette M, Iscoe N . Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma. Cancer. 2006; 106(7):1431-42. DOI: 10.1002/cncr.21760. View

10.

Morton D, Thompson J, Cochran A, Mozzillo N, Elashoff R, Essner R . Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006; 355(13):1307-17. DOI: 10.1056/NEJMoa060992. View

11.

Balch C, Cascinelli N . Sentinel-node biopsy in melanoma. N Engl J Med. 2006; 355(13):1370-1. DOI: 10.1056/NEJMe068147. View

12.

Retsas S . Sentinel-node biopsy in melanoma. N Engl J Med. 2007; 356(4):419. View

13.

Kanzler M, Levitt L, Lin A . Sentinel-node biopsy in melanoma. N Engl J Med. 2007; 356(4):419. View

14.

Balch C, Buzaid A, Soong S, Atkins M, Cascinelli N, Coit D . Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001; 19(16):3635-48. DOI: 10.1200/JCO.2001.19.16.3635. View

15.

Retsas S . Adjuvant therapy of malignant melanoma: is there a choice?. Crit Rev Oncol Hematol. 2001; 40(2):187-93. DOI: 10.1016/s1040-8428(01)00099-3. View

16.

Medalie N, Ackerman A . Sentinel lymph node biopsy has no benefit for patients with primary cutaneous melanoma metastatic to a lymph node: an assertion based on comprehensive, critical analysis: part I. Am J Dermatopathol. 2003; 25(5):399-417. DOI: 10.1097/00000372-200310000-00006. View